There is evidence that in patients with hypertension and CKD, regardless of diabetes status, renin-angiotensin system agents (ACE inhibitor or angiotensin receptor blocker [ARB]) have a protective effect on kidney function
If you want to change selection, open document below and click on "Move attachment"
- (no access) - MKSAP_17.pdf, p3390
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|